Clinical Trials Browser

OTHER × sacubitril and valsartan sodium hydrate drug combination × Endocrine × Clear all

NCT03647657 2022-02-10

177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Phase EARLY_PHASE1 Completed

EndocrineHead & Neck

Thyroid cancer, medullary, Carcinoma, Medullary